Big Data Training for Translational Omics Research. Session 1, Day 3, Liu. Case Study #2. PLOS Genetics DOI: /journal.pgen.

Size: px
Start display at page:

Download "Big Data Training for Translational Omics Research. Session 1, Day 3, Liu. Case Study #2. PLOS Genetics DOI: /journal.pgen."

Transcription

1 Session 1, Day 3, Liu Case Study #2 PLOS Genetics DOI: /journal.pgen

2 Enantiomer Mirror image Methadone

3 Methadone Kreek, 1973, 1976

4 Methadone Maintenance Therapy Long-term use of Methadone Plasma concentration of methadone is a primary index for quantifying and determining therapy responses to MMT What kind of biomarker is this? Invasive, cost, slow, non-predictive Other Markers? Plasma concentration During treatment Clinical response Before treatment

5 Metabolism Pathways Partially known Journal of Analytical Toxicology 2013;37:

6 Previous Candidate Gene-based Studies Anesthesiology 2015, Vol.123,

7 Previous Candidate Gene-based Studies Crettols et al., Clin Pharmacol Ther. 2006;80(6):668-81

8 Study Design Discovery set N=360 Validation set N=78 Phenotype Genotype Phenotype Genotype QC QC QC QC Candidate SNPs Candidate Haplotypes Confirmed SNPs Confirmed Haplotypes Evaluation

9 Why?

10 Covariates and Phenotypes Age, gender, BMI Race? The plasma concentrations of the methadone R- and S-enantiomers and their metabolites

11 Phenotypic data QC Top 5 percentile Bottom 5 percentile O r ig in a l W in s o r iz e d

12

13

14 Single Locus Association Multivariate linear regression covariates Genotype Phenotype Age Gender BMI Ancestry X

15 Haplotype-based Analysis Biological relevant: a haplotype is more likely to alter the overall function than a single allele Combining SNPs into haplotypes will reduce the data Increase the genotypic variance to increase power 2 2, 2 3, 2 4 Average length of a LD block in Asian/Cau~5 SNPs

16 R-Methadone: Single SNP Results Rs on chromosome 9àintergenic region S-Methadone, R-/S-EDDP no single SNP was significant after a multiple-test correction of the false discovery rate. AX (raw p = ), SPON1, Chr 11 rs (raw p = ), intergenic and AX (raw p = ), intergenic

17

18 Haplotype analysis Why haplotype analysis 5-SNP window Among the 25 most significant windows in each of the analyses of different window sizes, higher than 92.5% of the significant windows were overlapped. Second, in the study population, a window size of 5 provided a distribution of window width nearest to the distribution of the block size of the LD of the Asian population in the International HapMap II Project

19 Results R-Methadone: 4 windows: all intergenic 4 th window overlaps with rs S-Methadone: 23 windows: 17 haplotypes Chr 11: overlap with SPON1 Chr 16: GSG1L Chr 19: CYP450: CYP2B6 R-/S-EDDP None

20 SNP vs Phenotypic Variation Similar to a predictive model in biomarker discovery R-Methadone: Rs accounted for 9.541%: tagsnp of 4 in the LD block 4 haplotypes: 11.35% S-Methadone 17 significant haplotypes accounted for 23.96%

21 Validation and Replication 78 samples, same criteria, same array urine morphine test 5/17 haplotypes replicated at p<0.05 Together account for 17.95% and 19.51% of S-Methadone Same direction CYP2B6, SPON1, and GSG1L Rs : none

22 Mechanistic Constitutive androstane receptor (CAR)-activated coexpression of CYP2B6, SPON1, andgsg1l

23 rs Rs and heterochromatic histone H3 lysine 9 trimethylation (H3K9me3) in the primary T regulatory cells from peripheral blood (p-value signal score was ). Imputed information of 2-Mb flanking region of rs on chromosome 9 The imputed SNP rs at 82,938,858 bp (Raw p = ) was even more significant than rs at 82,944,201 bp (Raw p = ). All of the significant SNPs were located in intergenic regions.

24 Power and sample size Under powered?

25 Winner s Curse Is it really worth the value? Phenotype Winner Disease Does it really confer that high risk? Replication issue

26 Homework Projects Nonalcoholic Fatty liver disease (NAFLD) Normal Steatosis (NAFL) Steatohepatitis (NASH) Fibrosis/ cirrhosis

27 Background NAFLD is present in 30% US adults and 10-15% children By MRI in general population 35% - far higher in select population such as type 2 diabetics By CT and US about 15-17% By AST/ALT 7% Most common cause of elevated liver enzymes in both adults and children Up to 5% US adults may have NASH

28 Homework Projects Two set of questions: Overall phenotypes: NAFLD Two specific phenotypes: NAFLD vs Normal: binary Hepatic Fat Content (HFC): continuous Molecular data: Gene expression: 1000 genes SNPs: Chr1, Chr 2, Chr 3

29 Projects Project 1: Biomarker discovery for FLD Project 2: Biomarker discovery for HFC Project 3: GWAS for FLD (Choose from 1 Chr data) Project 4: GWAS for HFC (Choose from 1 Chr data)

30 Biomarker study: Deliverables A smallest number of genes as a signature. Explain your design strategy Explain your result Explain your future direction GWAS study: Top SNPs and the associated genes Explain your design strategy Explain your result Explain your future direction

31 Operation and Presentation Group discussion Team work TA guided 15-20min / group 5 min discussion

Supplementary Figure 1: Attenuation of association signals after conditioning for the lead SNP. a) attenuation of association signal at the 9p22.

Supplementary Figure 1: Attenuation of association signals after conditioning for the lead SNP. a) attenuation of association signal at the 9p22. Supplementary Figure 1: Attenuation of association signals after conditioning for the lead SNP. a) attenuation of association signal at the 9p22.32 PCOS locus after conditioning for the lead SNP rs10993397;

More information

Lipid and Bile Acids as NAFLD- Related Biomarkers

Lipid and Bile Acids as NAFLD- Related Biomarkers Lipid and Bile Acids as NAFLD- Related Biomarkers Puneet Puri, MBBS, MD Division of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University, Richmond, VA 1st International Workshop

More information

Tutorial on Genome-Wide Association Studies

Tutorial on Genome-Wide Association Studies Tutorial on Genome-Wide Association Studies Assistant Professor Institute for Computational Biology Department of Epidemiology and Biostatistics Case Western Reserve University Acknowledgements Dana Crawford

More information

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017 Large-scale identity-by-descent mapping discovers rare haplotypes of large effect Suyash Shringarpure 23andMe, Inc. ASHG 2017 1 Why care about rare variants of large effect? Months from randomization 2

More information

Accessing and Using ENCODE Data Dr. Peggy J. Farnham

Accessing and Using ENCODE Data Dr. Peggy J. Farnham 1 William M Keck Professor of Biochemistry Keck School of Medicine University of Southern California How many human genes are encoded in our 3x10 9 bp? C. elegans (worm) 959 cells and 1x10 8 bp 20,000

More information

CS2220 Introduction to Computational Biology

CS2220 Introduction to Computational Biology CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS

More information

Nash with cirrhosis icd 10

Nash with cirrhosis icd 10 Free, official coding info for 2018 ICD-10-CM K75.81 - includes detailed crosswalks, DRG grouping and more. Free, official coding info for 2018 ICD-10-CM K74.69 - includes detailed crosswalks, DRG grouping

More information

AAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease

AAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease AAIM: GI Workshop Follow Up to Case Studies Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease Daniel Zimmerman, MD VP and Medical Director, RGA Global October 2015 Non-alcoholic Fatty

More information

Supplemental Table 1. Components of MDS and AHEI

Supplemental Table 1. Components of MDS and AHEI Supplemental Table 1. Components of MDS and AHEI MDS AHEI Vegetable Fruit SSB & fruit juice Nut Legume Whole grain Fish Red meat MUFA/SAT ratio EPA & DHA PUFA Trans-fat Alcohol Sodium MDS: Mediterranean-style

More information

Non-Alcoholic Fatty Liver Diseasean underestimated epidemic

Non-Alcoholic Fatty Liver Diseasean underestimated epidemic Non-Alcoholic Fatty Liver Diseasean underestimated epidemic Amir Shlomai MD,PhD Head, Department of Medicine D The Liver Institute Rabin Medical Center, Beilinson Hospital The IASLD semi-annual meeting-

More information

UMHS-PUHSC JOINT INSTITUTE

UMHS-PUHSC JOINT INSTITUTE Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,

More information

DIAGNOSIS OF NASH LIVER BIOPSY. PHC

DIAGNOSIS OF NASH LIVER BIOPSY. PHC DIAGNOSIS OF NASH LIVER BIOPSY PHC 2018 - www.aphc.info 1 THE NATURAL HISTORY OF NAFLD STEATOSIS (NAFL) STEATOHEPATITIS (NASH) FIBROSIS CIRRHOSIS HCC UNDER THE LENS : THE 3 HISTOLOGICAL COMPONENTS OF NAFLD

More information

New Enhancements: GWAS Workflows with SVS

New Enhancements: GWAS Workflows with SVS New Enhancements: GWAS Workflows with SVS August 9 th, 2017 Gabe Rudy VP Product & Engineering 20 most promising Biotech Technology Providers Top 10 Analytics Solution Providers Hype Cycle for Life sciences

More information

Ct=28.4 WAT 92.6% Hepatic CE (mg/g) P=3.6x10-08 Plasma Cholesterol (mg/dl)

Ct=28.4 WAT 92.6% Hepatic CE (mg/g) P=3.6x10-08 Plasma Cholesterol (mg/dl) a Control AAV mtm6sf-shrna8 Ct=4.3 Ct=8.4 Ct=8.8 Ct=8.9 Ct=.8 Ct=.5 Relative TM6SF mrna Level P=.5 X -5 b.5 Liver WAT Small intestine Relative TM6SF mrna Level..5 9.6% Control AAV mtm6sf-shrna mtm6sf-shrna6

More information

An Introduction to Quantitative Genetics I. Heather A Lawson Advanced Genetics Spring2018

An Introduction to Quantitative Genetics I. Heather A Lawson Advanced Genetics Spring2018 An Introduction to Quantitative Genetics I Heather A Lawson Advanced Genetics Spring2018 Outline What is Quantitative Genetics? Genotypic Values and Genetic Effects Heritability Linkage Disequilibrium

More information

Introduction to Genetics and Genomics

Introduction to Genetics and Genomics 2016 Introduction to enetics and enomics 3. ssociation Studies ggibson.gt@gmail.com http://www.cig.gatech.edu Outline eneral overview of association studies Sample results hree steps to WS: primary scan,

More information

LIVER PATHOLOGY. Thursday 28 th November 2013

LIVER PATHOLOGY. Thursday 28 th November 2013 LIVER PATHOLOGY Thursday 28 th November 2013 Liver biopsy assessment of steatosis Amar Paul Dhillon Royal Free Hospital RIBA, London Thursday 28th November 2013 NAFLD didn t exist before 2001 and liver

More information

University of Groningen. Non-alcoholic fatty liver disease Sheedfar, Fareeba

University of Groningen. Non-alcoholic fatty liver disease Sheedfar, Fareeba University of Groningen Non-alcoholic fatty liver disease Sheedfar, Fareeba IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check

More information

Understanding your FibroScan Results

Understanding your FibroScan Results PATIENT & CAREGIVER EDUCATION Understanding your FibroScan Results This information will help you understand your FibroScan results. About FibroScan FibroScan is a specialized ultrasound machine for your

More information

A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy

A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy International Workshop on NASH Biomarkers May 5-6 2017, Washington D.C. Pablo Ortiz, MD, PhD (OWL CEO)

More information

Global variation in copy number in the human genome

Global variation in copy number in the human genome Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)

More information

Defining the gold standard in biomarker validation for NASH

Defining the gold standard in biomarker validation for NASH Defining the gold standard in biomarker validation for NASH Arun J Sanyal M.D. Professor of Medicine, Physiology and Molecular Pathology Virginia Commonwealth University School of Medicine Conflicts of

More information

Supplementary Figure 1. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations.

Supplementary Figure 1. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations. Supplementary Figure. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations. a Eigenvector 2.5..5.5. African Americans European Americans e

More information

Mendelian Randomization

Mendelian Randomization Mendelian Randomization Drawback with observational studies Risk factor X Y Outcome Risk factor X? Y Outcome C (Unobserved) Confounders The power of genetics Intermediate phenotype (risk factor) Genetic

More information

The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0

The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0 The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0 Introduction Loss of erozygosity (LOH) represents the loss of allelic differences. The SNP markers on the SNP Array 6.0 can be used

More information

Heritability enrichment of differentially expressed genes. Hilary Finucane PGC Statistical Analysis Call January 26, 2016

Heritability enrichment of differentially expressed genes. Hilary Finucane PGC Statistical Analysis Call January 26, 2016 Heritability enrichment of differentially expressed genes Hilary Finucane PGC Statistical Analysis Call January 26, 2016 1 Functional genomics + GWAS gives insight into disease relevant tissues Trynka

More information

A rare variant in MYH6 confers high risk of sick sinus syndrome. Hilma Hólm ESC Congress 2011 Paris, France

A rare variant in MYH6 confers high risk of sick sinus syndrome. Hilma Hólm ESC Congress 2011 Paris, France A rare variant in MYH6 confers high risk of sick sinus syndrome Hilma Hólm ESC Congress 2011 Paris, France Disclosures I am an employee of decode genetics, Reykjavik, Iceland. Sick sinus syndrome SSS is

More information

Liver biopsy as the gold standard for diagnosis. Pierre BEDOSSA

Liver biopsy as the gold standard for diagnosis. Pierre BEDOSSA Liver biopsy as the gold standard for diagnosis Pierre BEDOSSA 1 PATHOLOGY OF NAFLD CONFLICTS OF INTEREST Grants and funding from Genfit, Intercept, Allergan, Inventiva, OWL, Echosens CEO and funding of

More information

NON-ALCOHOLIC FATTY LIVER DISEASE:

NON-ALCOHOLIC FATTY LIVER DISEASE: NON-ALCOHOLIC FATTY LIVER DISEASE: ROLE OF THE PRIMARY PROVIDER Archita P. Desai, MD Assistant Professor of Medicine University of Arizona 25 th Annual Southwestern Conference on Medicine Outline Pathophysiology

More information

Liver Fat Quantification

Liver Fat Quantification Liver Fat Quantification Jie Deng, PhD, DABMP Department of Medical Imaging May 18 th, 2017 Disclosure Research agreement with Siemens Medical Solutions 2 Background Non-alcoholic fatty liver diseases

More information

Utility of Pharmacogenomics to Identify and Limit CV Risk. Christopher B. Granger, MD

Utility of Pharmacogenomics to Identify and Limit CV Risk. Christopher B. Granger, MD Utility of Pharmacogenomics to Identify and Limit CV Risk Christopher B. Granger, MD Disclosure Research contracts: AstraZeneca, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company, and Boehringer

More information

PHC, Paris, 30th Jan 2017 PATHOLOGY OF NAFLD. Pierre Bedossa. Departement of Pathology Hôpital Beaujon University Paris-Diderot Paris - FRANCE

PHC, Paris, 30th Jan 2017 PATHOLOGY OF NAFLD. Pierre Bedossa. Departement of Pathology Hôpital Beaujon University Paris-Diderot Paris - FRANCE PHC, Paris, 30th Jan 2017 PATHOLOGY OF NAFLD Pierre Bedossa Departement of Pathology Hôpital Beaujon University Paris-Diderot Paris - FRANCE 1 PATHOLOGY OF NAFLD NAFLD: a chronic liver disease with a wide

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Kerby Shedden, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike 3.0 License: http://creativecommons.org/licenses/by-sa/3.0/

More information

Case #1. Digital Slides 11/6/ year old woman presented with abnormal liver function tests. Liver Biopsy to r/o autoimmune hepatitis

Case #1. Digital Slides 11/6/ year old woman presented with abnormal liver function tests. Liver Biopsy to r/o autoimmune hepatitis 45 year old woman presented with abnormal liver function tests Liver Biopsy to r/o autoimmune hepatitis Further down. ANA 1: 160; ASMA 1:80 ANA 1: 160; ASMA 1:80 IgG = 14.5 g/l (upper normal range: 16)

More information

Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Non-Alcoholic Fatty Liver Disease None Disclosures Arslan Kahloon M.D Chief, Division of Gastroenterology and Hepatology University of Tennessee College of Medicine Chattanooga Objectives Understand the

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Fig 1. Comparison of sub-samples on the first two principal components of genetic variation. TheBritishsampleisplottedwithredpoints.The sub-samples of the diverse sample

More information

White Paper Guidelines on Vetting Genetic Associations

White Paper Guidelines on Vetting Genetic Associations White Paper 23-03 Guidelines on Vetting Genetic Associations Authors: Andro Hsu Brian Naughton Shirley Wu Created: November 14, 2007 Revised: February 14, 2008 Revised: June 10, 2010 (see end of document

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTRY INFORMTION Supplementary Figure 1. Q-Q plot of RE/NIMH autism family TDT results. The quantile-quantile plot of the expected and observed P-values is shown. The blue circles represent the

More information

Genomic structural variation

Genomic structural variation Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural

More information

Liver Pathology in the 0bese

Liver Pathology in the 0bese Liver Pathology in the 0bese Rob Goldin Centre for Pathology, Imperial College r.goldin@imperial.ac.uk Ludwig et al. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

More information

Assessing Accuracy of Genotype Imputation in American Indians

Assessing Accuracy of Genotype Imputation in American Indians Assessing Accuracy of Genotype Imputation in American Indians Alka Malhotra*, Sayuko Kobes, Clifton Bogardus, William C. Knowler, Leslie J. Baier, Robert L. Hanson Phoenix Epidemiology and Clinical Research

More information

# For the GWAS stage, B-cell NHL cases which small numbers (N<20) were excluded from analysis.

# For the GWAS stage, B-cell NHL cases which small numbers (N<20) were excluded from analysis. Supplementary Table 1a. Subtype Breakdown of all analyzed samples Stage GWAS Singapore Validation 1 Guangzhou Validation 2 Guangzhou Validation 3 Beijing Total No. of B-Cell Cases 253 # 168^ 294^ 713^

More information

Role of Genomics in Selection of Beef Cattle for Healthfulness Characteristics

Role of Genomics in Selection of Beef Cattle for Healthfulness Characteristics Role of Genomics in Selection of Beef Cattle for Healthfulness Characteristics Dorian Garrick dorian@iastate.edu Iowa State University & National Beef Cattle Evaluation Consortium Selection and Prediction

More information

The omics approach in measuring the double burden of malnutrition

The omics approach in measuring the double burden of malnutrition IAEA Headquarter, Vienna, Austria, 3-5 October 2017 Joint IAEA-WHO-UNICEF workshop on analysis of biological pathways to better understand the double burden of malnutrition and to inform action planning

More information

Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis

Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis Alina M. Allen, Meng Yin, Sudhakar K. Venkatesh, Taofic Mounajjed, Todd A. Kellogg,

More information

Bariatric Surgery and Liver Transplantation

Bariatric Surgery and Liver Transplantation Bariatric Surgery and Liver Transplantation Sammy Saab, MD, MPH, AGAF, FACG, FAASLD Professor of Medicine and Surgery Head, Outcomes Research in Hepatology David Geffen School of Medicine at UCLA Disclosures

More information

Nonalcoholic Fatty Liver Disease (NAFLD)

Nonalcoholic Fatty Liver Disease (NAFLD) Nonalcoholic Fatty Liver Disease (NAFLD) What is Nonalcoholic Fatty Liver Disease? It is normal for the liver to contain some fat. Sometimes, however, too much fat can build up in the liver. When fat makes

More information

Pirna Sequence Variants Associated With Prostate Cancer In African Americans And Caucasians

Pirna Sequence Variants Associated With Prostate Cancer In African Americans And Caucasians Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Pirna Sequence Variants Associated With Prostate Cancer In African

More information

Supplementary Figure 1. Quantile-quantile (Q-Q) plot of the log 10 p-value association results from logistic regression models for prostate cancer

Supplementary Figure 1. Quantile-quantile (Q-Q) plot of the log 10 p-value association results from logistic regression models for prostate cancer Supplementary Figure 1. Quantile-quantile (Q-Q) plot of the log 10 p-value association results from logistic regression models for prostate cancer risk in stage 1 (red) and after removing any SNPs within

More information

Genetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder)

Genetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder) Genetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder) September 14, 2012 Chun Xu M.D, M.Sc, Ph.D. Assistant professor Texas Tech University Health Sciences Center Paul

More information

Improving Access to Quality Medical Care Webinar Series

Improving Access to Quality Medical Care Webinar Series Improving Access to Quality Medical Care Webinar Series Presented by The Arizona Telemedicine Program and the Southwest Telehealth Resource Center 2015 UA Board of Regents Welcome AZ, UT, CO, NM & NV FLEX

More information

ttitle OF TALK 5/18/2016 Epigenetics Marks on genes that retune metabolism. We assume people are average

ttitle OF TALK 5/18/2016 Epigenetics Marks on genes that retune metabolism. We assume people are average PRECISION (PERSONALIZED) NUTRITION ttitle OF TALK STEVEN H. ZEISEL M.D., Ph.D. Professor of Nutrition and Pediatrics University of North Carolina at Chapel Hill Director, UNC Nutrition Research Institute

More information

Doing more with genetics: Gene-environment interactions

Doing more with genetics: Gene-environment interactions 2016 Alzheimer Disease Centers Clinical Core Leaders Meeting Doing more with genetics: Gene-environment interactions Haydeh Payami, PhD On behalf of NeuroGenetics Research Consortium (NGRC) From: Joseph

More information

GENOME-WIDE ASSOCIATION STUDIES

GENOME-WIDE ASSOCIATION STUDIES GENOME-WIDE ASSOCIATION STUDIES SUCCESSES AND PITFALLS IBT 2012 Human Genetics & Molecular Medicine Zané Lombard IDENTIFYING DISEASE GENES??? Nature, 15 Feb 2001 Science, 16 Feb 2001 IDENTIFYING DISEASE

More information

Complex Trait Genetics in Animal Models. Will Valdar Oxford University

Complex Trait Genetics in Animal Models. Will Valdar Oxford University Complex Trait Genetics in Animal Models Will Valdar Oxford University Mapping Genes for Quantitative Traits in Outbred Mice Will Valdar Oxford University What s so great about mice? Share ~99% of genes

More information

Introduction to the Genetics of Complex Disease

Introduction to the Genetics of Complex Disease Introduction to the Genetics of Complex Disease Jeremiah M. Scharf, MD, PhD Departments of Neurology, Psychiatry and Center for Human Genetic Research Massachusetts General Hospital Breakthroughs in Genome

More information

Jose D Sollano, MD Professor of Medicine University of Santo Tomas Manila, Philippines. University of Santo Tomas

Jose D Sollano, MD Professor of Medicine University of Santo Tomas Manila, Philippines. University of Santo Tomas Jose D Sollano, MD Professor of Medicine Manila, Philippines International Variation in Age-Standardized Liver Cancer Incidence Rates in Both Sexes, 2008 Global Age-Standardized Liver Cancer Incidence

More information

NONALCOHOLIC FATTY LIVER DISEASE. Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD. April 13, 2012

NONALCOHOLIC FATTY LIVER DISEASE. Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD. April 13, 2012 NONALCOHOLIC FATTY LIVER DISEASE Kiran Bambha, MD University of Colorado Denver April 13, 2012 Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD Simple Steatosis Fatty hepatocytes Intracellular fat

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

Non-Alcoholic Fatty Liver Disease (NAFLD)

Non-Alcoholic Fatty Liver Disease (NAFLD) HEPATO-PANCREATO-BILIARY STOMACH CANCER PROGRAM Non-Alcoholic Fatty Liver Disease (NAFLD) Steatosis and Non-Alcoholic Steatohepatitis (NASH) Management Recommendations UCSF Fresno Department of Surgery

More information

American Psychiatric Nurses Association

American Psychiatric Nurses Association Francis J. McMahon International Society of Psychiatric Genetics Johns Hopkins University School of Medicine Dept. of Psychiatry Human Genetics Branch, National Institute of Mental Health* * views expressed

More information

indicated in shaded lowercase letters (hg19, Chr2: 217,955, ,957,266).

indicated in shaded lowercase letters (hg19, Chr2: 217,955, ,957,266). Legend for Supplementary Figures Figure S1: Sequence of 2q35 encnv. The DNA sequence of the 1,375bp 2q35 encnv is indicated in shaded lowercase letters (hg19, Chr2: 217,955,892-217,957,266). Figure S2:

More information

Quantitative Assessment of the Liver: Breath Tests. M. Shadab Siddiqui, M.D. Virginia Commonwealth University

Quantitative Assessment of the Liver: Breath Tests. M. Shadab Siddiqui, M.D. Virginia Commonwealth University Quantitative Assessment of the Liver: Breath Tests M. Shadab Siddiqui, M.D. Virginia Commonwealth University Objectives Principles of breath tests Breath tests in NAFLD Potential applications of breath

More information

Early life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016.

Early life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016. Early life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016. Outline Definition NAFLD and NASH Magnitude of the problem

More information

Supplementary note: Comparison of deletion variants identified in this study and four earlier studies

Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Here we compare the results of this study to potentially overlapping results from four earlier studies

More information

Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia

Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia Xueling Sim 1, Rick Twee-Hee Ong 1,2,3, Chen Suo 1, Wan-Ting Tay 4, Jianjun Liu 3, Daniel Peng-Keat Ng 5,

More information

PEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE

PEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE PEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE Updates on New insights into NAFLD and NASH pathophysiology New AASLD/AGA/ACG guidelines for NAFLD and NASH, as pertains to pediatrics Evidence-based

More information

Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis

Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis Supplementary Material Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis Kwangwoo Kim 1,, So-Young Bang 1,, Katsunori Ikari 2,3, Dae

More information

Paola Nicoletti, Harshad Devarbhavi, Ashish Goel, CE Eapen, Radha Venkatesan, Jane I Grove, Ann K Daly and Guruprasad P. Aithal

Paola Nicoletti, Harshad Devarbhavi, Ashish Goel, CE Eapen, Radha Venkatesan, Jane I Grove, Ann K Daly and Guruprasad P. Aithal Genome-wide association study (GWAS) to identify genetic risk factors that increase susceptibility to antituberculosis drug-induced liver injury (ATDILI) Paola Nicoletti, Harshad Devarbhavi, Ashish Goel,

More information

10/19/2017. How Nutritional Genomics Affects You in Nutrition Research and Practice Joyanna Hansen, PhD, RD & Kristin Guertin, PhD, MPH

10/19/2017. How Nutritional Genomics Affects You in Nutrition Research and Practice Joyanna Hansen, PhD, RD & Kristin Guertin, PhD, MPH Disclosures Joyanna Hansen How Affects You in Nutrition Research and Practice Joyanna Hansen, PhD, RD & Kristin Guertin, PhD, MPH Consultant Nutricia North America Research Support Academy of Nutrition

More information

Chewing the Fat on Fatty Liver Mike Kolber MD, CCFP, MSc PEIP 2018

Chewing the Fat on Fatty Liver Mike Kolber MD, CCFP, MSc PEIP 2018 Chewing the Fat on Fatty Liver Mike Kolber MD, CCFP, MSc PEIP 2018 Faculty/Presenter Disclosure Faculty: Michael Kolber Relationships with financial sponsors: Grants/Research Support: Alberta College of

More information

Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com. Thursday, April 11, 13

Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com. Thursday, April 11, 13 Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com 1 Outline Recessive model Examples of Compound Heterozygosity Compound Double Heterozygosity (CDH) test 2 Recessive

More information

M30 Apoptosense ELISA. A biomarker assay for detection and screening of NASH

M30 Apoptosense ELISA. A biomarker assay for detection and screening of NASH M30 Apoptosense ELISA A biomarker assay for detection and screening of NASH NASH A Global Disease In the Western countries, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease, strongly

More information

Imaging Genetics: Heritability, Linkage & Association

Imaging Genetics: Heritability, Linkage & Association Imaging Genetics: Heritability, Linkage & Association David C. Glahn, PhD Olin Neuropsychiatry Research Center & Department of Psychiatry, Yale University July 17, 2011 Memory Activation & APOE ε4 Risk

More information

NAFLD: evidence-based management. Curso de residentes AEEH Salvador Augustin, MD Liver Unit Vall d Hebron Hospital Barcelona, Spain

NAFLD: evidence-based management. Curso de residentes AEEH Salvador Augustin, MD Liver Unit Vall d Hebron Hospital Barcelona, Spain NAFLD: evidence-based management Curso de residentes AEEH 2017 Salvador Augustin, MD Liver Unit Vall d Hebron Hospital Barcelona, Spain Clinical case - 55 yo female - Sent for incidental steatosis at abdominal

More information

Title:Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population

Title:Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population Author's response to reviews Title:Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population Authors: Jin-Kyu Park (cardiohy@gmail.com)

More information

Introduction of Genome wide Complex Trait Analysis (GCTA) Presenter: Yue Ming Chen Location: Stat Gen Workshop Date: 6/7/2013

Introduction of Genome wide Complex Trait Analysis (GCTA) Presenter: Yue Ming Chen Location: Stat Gen Workshop Date: 6/7/2013 Introduction of Genome wide Complex Trait Analysis (GCTA) resenter: ue Ming Chen Location: Stat Gen Workshop Date: 6/7/013 Outline Brief review of quantitative genetics Overview of GCTA Ideas Main functions

More information

/ FIB4 Index , simple steatosis. FIB4 Index. FIB4 Index. FIB4 Index FIB4 Index. Sterling FIB4 Index. FIB4 Index AST AST ALT

/ FIB4 Index , simple steatosis. FIB4 Index. FIB4 Index. FIB4 Index FIB4 Index. Sterling FIB4 Index. FIB4 Index AST AST ALT 原 著 29 34-41, 2014 FIB4 Index 1 1 1 1 2 1 1 FIB4 Index FIB4 Index cut off 2.67 2.67 12,059 FIB4 IndexFIB4 Index 2.67 / FIB4 Index AST ALT FIB4 Index 2.67 161 1.3% FIB4 Index 5 FIB4 Index 1.1 5 1.6 FIB4

More information

NASH Bench to Bedside

NASH Bench to Bedside NASH Bench to Bedside October 2006 Anna Mae Diehl, M.D. Gastroenterology Division Duke University NonAlcoholic Fatty Liver Disease Common ~1/4-1/3 1/3 US adults Outcome highly variable Course indolent

More information

Dementia. Inhibition of vascular calcification

Dementia. Inhibition of vascular calcification FLEMENGHO Dementia Inhibition of vascular calcification Role of matrix Gla protein Yan-Ping Liu, Fang-Fei Wei, Cees Vermeer, and Jan A. Staessen, Research Unit Hypertension and Cardiovascular Epidemiology,

More information

Variation in PNPLA3 is associated with outcomes. in alcoholic liver disease

Variation in PNPLA3 is associated with outcomes. in alcoholic liver disease Variation in PNPLA3 is associated with outcomes in alcoholic liver disease Chao Tian 1, Renee P. Stokowski 1, David Kershenobich 2, Dennis G. Ballinger 1,3, David A. Hinds 1 1. Perlegen, 2021 Stierlin

More information

GWAS of HCC Proposed Statistical Approach Mendelian Randomization and Mediation Analysis. Chris Amos Manal Hassan Lewis Roberts Donghui Li

GWAS of HCC Proposed Statistical Approach Mendelian Randomization and Mediation Analysis. Chris Amos Manal Hassan Lewis Roberts Donghui Li GWAS of HCC Proposed Statistical Approach Mendelian Randomization and Mediation Analysis Chris Amos Manal Hassan Lewis Roberts Donghui Li Overall Design of GWAS Study Aim 1 (DISCOVERY PHASE): To genotype

More information

Utilizing Seamless Adaptive Designs and Considering Multiplicity Adjustment for NASH Clinical Trials

Utilizing Seamless Adaptive Designs and Considering Multiplicity Adjustment for NASH Clinical Trials Utilizing Seamless Adaptive Designs and Considering Multiplicity Adjustment for NASH Clinical Trials Yeh-Fong Chen FDA/CDER/OB/DB3 Forum for Collaborative Research (Berkeley) 5/10/2017 Disclaimer This

More information

Prognosis of NASH VII Workshop Intenracional de Actualizaçao em Hepatologia, Aug 29th 2014

Prognosis of NASH VII Workshop Intenracional de Actualizaçao em Hepatologia, Aug 29th 2014 Prognosis of NASH VII Workshop Intenracional de Actualizaçao em Hepatologia, Aug 29th 2014 Vlad Ratziu, Université Pierre et Marie Curie, Hôpital Pitié Salpêtrière, Paris, France NASH : a severe hepatic

More information

Preface: Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic

Preface: Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic NASH and NAFLD Preface: Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic David E. Bernstein xiii Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

More information

Genome-Wide Localization of Protein-DNA Binding and Histone Modification by a Bayesian Change-Point Method with ChIP-seq Data

Genome-Wide Localization of Protein-DNA Binding and Histone Modification by a Bayesian Change-Point Method with ChIP-seq Data Genome-Wide Localization of Protein-DNA Binding and Histone Modification by a Bayesian Change-Point Method with ChIP-seq Data Haipeng Xing, Yifan Mo, Will Liao, Michael Q. Zhang Clayton Davis and Geoffrey

More information

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics Copy Number Variations and Association Mapping 02-715 Advanced Topics in Computa8onal Genomics SNP and CNV Genotyping SNP genotyping assumes two copy numbers at each locus (i.e., no CNVs) CNV genotyping

More information

A Genome-wide Association Study in Han Chinese Identifies Multiple. Susceptibility loci for IgA Nephropathy. Supplementary Material

A Genome-wide Association Study in Han Chinese Identifies Multiple. Susceptibility loci for IgA Nephropathy. Supplementary Material A Genome-wide Association Study in Han Chinese Identifies Multiple Susceptibility loci for IgA Nephropathy Supplementary Material Xue-Qing Yu 1,13, Ming Li 1,13, Hong Zhang 2,13, Hui-Qi Low 3, Xin Wei

More information

NONALCOHOLIC FATTY LIVER DISEASE

NONALCOHOLIC FATTY LIVER DISEASE NONALCOHOLIC FATTY LIVER DISEASE Kiran Bambha, MD, MSc Hepatology and Liver Transplantation University of Colorado Denver April 13, 2012 Non-Alcoholic Fatty Liver Disease (NAFLD) Terminology Pathogenesis

More information

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Update on Nonalcoholic Fatty Liver Disease Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Outline Defining the phenotypes of nonalcoholic fatty liver disease NAFLD Diagnostics

More information

GARRY R. CUTTING, MD PROFESSOR OF MEDICAL GENETICS DIRECTOR OF THE DNA DIAGNOSTIC LABORATORY THE JOHNS HOPKINS UNIVERSITY BALTIMORE, MARYLAND

GARRY R. CUTTING, MD PROFESSOR OF MEDICAL GENETICS DIRECTOR OF THE DNA DIAGNOSTIC LABORATORY THE JOHNS HOPKINS UNIVERSITY BALTIMORE, MARYLAND GARRY R. CUTTING, MD PROFESSOR OF MEDICAL GENETICS DIRECTOR OF THE DNA DIAGNOSTIC LABORATORY THE JOHNS HOPKINS UNIVERSITY BALTIMORE, MARYLAND MODIFIERS OF CYSTIC FIBROSIS LUNG FUNCTION MEASURES IN CF PATIENTS

More information

Normal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos

Normal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos Fatty liver disease Its not just for big boys anymore Ken Flora, MD, FAASLD, FACG, AGAF No disclosures Common situation Normal ALT for men 30 IU/L 36% US males abnormal Normal ALT for women 20 IU/L 28%

More information

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology Nonalcoholic steatohepatitis and Fatty Liver Disease Liver manifestations of the obesity epidemic Changes

More information

Pharmacogenetics and clinical opioid efficacy. Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway

Pharmacogenetics and clinical opioid efficacy. Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway Pharmacogenetics and clinical opioid efficacy Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway Variation in opioid dose Variation in effects from different

More information

Statistical Tests for X Chromosome Association Study. with Simulations. Jian Wang July 10, 2012

Statistical Tests for X Chromosome Association Study. with Simulations. Jian Wang July 10, 2012 Statistical Tests for X Chromosome Association Study with Simulations Jian Wang July 10, 2012 Statistical Tests Zheng G, et al. 2007. Testing association for markers on the X chromosome. Genetic Epidemiology

More information

Hepatocellular Carcinoma Surveillance

Hepatocellular Carcinoma Surveillance Amit G. Singal, MD, MS Hepatocellular Carcinoma Surveillance Postgraduate Course: Challenges in Management of Common Liver Diseases 308 1 Patient Case 69 year-old otherwise healthy male with compensated

More information

Diseases to Watch. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic

Diseases to Watch. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Diseases to Watch Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) - Prevalence and Symptoms - Risk Factors and Potential treatments - Target identification for NASH Robert

More information

NAFLD AND TYPE 2 DIABETES

NAFLD AND TYPE 2 DIABETES NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213

More information

Lecture 20. Disease Genetics

Lecture 20. Disease Genetics Lecture 20. Disease Genetics Michael Schatz April 12 2018 JHU 600.749: Applied Comparative Genomics Part 1: Pre-genome Era Sickle Cell Anaemia Sickle-cell anaemia (SCA) is an abnormality in the oxygen-carrying

More information